Showing results (21-30 of 287) with videos related to

Sort By:
Pageof 29
Psychopharmacology Series|January 1, 1988
PET scanning--a new tool in clinical psychopharmacologyG Sedvall, L Farde, H Hall, et al.
Psychopharmacology|October 1, 1995
Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patientsP Karlsson, L Smith, L Farde, et al.
Nuclear Medicine and Biology|November 14, 1997
[125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brainI Günther, H Hall, C Halldin, et al.
Psychopharmacology|January 1, 1988
An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PETL Farde, F A Wiesel, P Jansson, et al.
The American Journal of Psychiatry|October 1, 1995
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patientsA L Nordström, L Farde, S Nyberg, et al.
EXS|January 1, 1994
PET-determination of benzodiazepine receptor binding in studies on alcoholismL Farde, S Pauli, J E Litton, et al.
The Israel Journal of Psychiatry and Related Sciences|January 1, 1995
Recent developments in PET scan imaging of neuroreceptors in schizophreniaG Sedvall, S Pauli, L Farde, et al.
Synapse (New York, N.Y.)|June 1, 1996
Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epideprideH Hall, L Farde, C Halldin, et al.
Psychopharmacology|May 1, 1995
Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in manP Karlsson, L Farde, C Halldin, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1994
Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's diseaseG Sedvall, P Karlsson, A Lundin, et al.
Pageof 29